30481-54-0Relevant articles and documents
Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors
Desai, Dhimant,Lauver, Matthew,Ostman, Alexandria,Cruz, Linda,Ferguson, Kevin,Jin, Ge,Roper, Brianne,Brosius, Daniel,Lukacher, Aron,Amin, Shantu,Buchkovich, Nick
, p. 1795 - 1803 (2019)
Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to inhibit the replication of two very different viruses. These observations open up the possibility of pan-viral inhibitors for immunosuppressed individuals that are effective against multiple, diverse opportunistic viruses.
One-Pot, Multistep Reactions for the Modular Synthesis of N, N′-Diarylindazol-3-ones
Liu, Shuai,Xu, Liang,Wei, Yu
, p. 1596 - 1604 (2019/02/07)
The pot-economic synthesis of N,N′-diarylindazol-3-ones has been developed using readily available isatoic anhydrides, aryl amines, and aryl boronic acids. A Cu-catalyzed oxidative C-N cross-coupling and dehydrogenative N-N formation sequence under an air atmosphere affords indazol-3-one derivatives in good to excellent yields. Such process merges well with the preceding decarboxylative amination reaction, resulting in a more modular and straightforward approach.
NONTOXIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF HERPESVIRUS INFECTIONS
-
Page/Page column 56; 57, (2018/02/14)
Compositions for preventing or treating virus infections inhibit the biogenesis of cytoplasmic viral assembly compartment (cVAC). The preferred compounds are dihydroquinazolinones.